James Kihara, PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 1,790 shares at $17.87 ($32K) on 2024-04-08, disclosed to the SEC on 2024-04-09.
Scheduled sale ($32k) by PRINCIPAL ACCOUNTING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.87 | 762 | $14K | 42.6% |
| 2 | $17.87 | 1,028 | $18K | 57.4% |
| Total | $17.87 avg | 1,790 | $32K | 100% |
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |